Search Results - "LUPI, Monica"
-
1
Local Health Department Values and Organizational Authorities Guiding Cross-Sector Work During COVID-19
Published in Health promotion practice (01-07-2024)“…Objective The COVID-19 pandemic highlighted the role that local health departments (LHDs) have in cross sector can address alone, including the work of value…”
Get full text
Journal Article -
2
DNA Damage Response Inhibitor Combinations Exert Synergistic Antitumor Activity in Aggressive B-Cell Lymphomas
Published in Molecular cancer therapeutics (01-07-2019)“…The DNA damage response (DDR) kinases ATR, Chk1, and Wee1 play vital roles in the response to replication stress and in maintaining cancer genomic stability…”
Get full text
Journal Article -
3
Combined inhibition of Chk1 and Wee1: In vitro synergistic effect translates to tumor growth inhibition in vivo
Published in Cell cycle (Georgetown, Tex.) (01-07-2012)“…Targeting Chk1 protein kinase can enhance the antitumor effects of radio- and chemotherapy. Recent evidence disclosed a role of Chk1 in unperturbed cell…”
Get full text
Journal Article -
4
ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells
Published in Haematologica (Roma) (01-03-2019)“…B-cell precursor-acute lymphoblastic leukemia modulates the bone marrow (BM) niche to become leukemia-supporting and chemo-protective by reprogramming the…”
Get full text
Journal Article -
5
-
6
Epithelioid Pleural Mesothelioma Is Characterized by Tertiary Lymphoid Structures in Long Survivors: Results from the MATCH Study
Published in International journal of molecular sciences (21-05-2022)“…Pleural mesothelioma (PM) is an aggressive tumor with few therapeutic options. Although patients with epithelioid PM (ePM) survive longer than non-epithelioid…”
Get full text
Journal Article -
7
In Vitro and In Vivo Activity of Lucitanib in FGFR1/2 Amplified or Mutated Cancer Models
Published in Neoplasia (New York, N.Y.) (01-01-2017)“…Abstract The fibroblast growth factor receptor (FGFR) pathway has been implicated both as an escape mechanism from anti-angiogenic therapy and as a driver…”
Get full text
Journal Article -
8
Dynamic rendering of the heterogeneous cell response to anticancer treatments
Published in PLoS computational biology (01-10-2013)“…The antiproliferative response to anticancer treatment is the result of concurrent responses in all cell cycle phases, extending over several cell generations,…”
Get full text
Journal Article -
9
Role of cardiolipins, mitochondria, and autophagy in the differentiation process activated by all-trans retinoic acid in acute promyelocytic leukemia
Published in Cell death & disease (10-01-2022)“…The role played by lipids in the process of granulocytic differentiation activated by all-trans retinoic acid (ATRA) in Acute-Promyelocytic-Leukemia (APL)…”
Get full text
Journal Article -
10
Tumor treating fields affect mesothelioma cell proliferation by exerting histotype-dependent cell cycle checkpoint activations and transcriptional modulations
Published in Cell death & disease (15-07-2022)“…Although clinical antitumor activity of Tumor Treating Fields (TTFields) has been reported in malignant pleural mesothelioma (MPM) patients, the mechanisms…”
Get full text
Journal Article -
11
Cellular and molecular determinants of all‐trans retinoic acid sensitivity in breast cancer: Luminal phenotype and RARα expression
Published in EMBO molecular medicine (01-07-2015)“…Forty‐two cell lines recapitulating mammary carcinoma heterogeneity were profiled for all‐ trans retinoic acid (ATRA) sensitivity. Luminal and ER +…”
Get full text
Journal Article -
12
Role of mitochondria and cardiolipins in growth inhibition of breast cancer cells by retinoic acid
Published in Journal of experimental & clinical cancer research (29-10-2019)“…All-trans-retinoic-acid (ATRA) is a promising agent in the prevention/treatment of breast-cancer. There is growing evidence that reprogramming of cellular…”
Get full text
Journal Article -
13
Glutaminase Inhibition on NSCLC Depends on Extracellular Alanine Exploitation
Published in Cells (Basel, Switzerland) (23-07-2020)“…Non-small-cell lung cancer (NSCLC) cell lines vary in their sensitivity to glutaminase inhibitors, so it is important to identify the metabolic assets…”
Get full text
Journal Article -
14
Correction to: Role of mitochondria and cardiolipins in growth inhibition of breast cancer cells by retinoic acid
Published in Journal of experimental & clinical cancer research (18-12-2019)“…In the original publication of this article [1], the images of Figs. 4 and 5 were exchanged and the legends of the two figures did not correspond due to a…”
Get full text
Journal Article -
15
Trypsinogen 4 boosts tumor endothelial cells migration through proteolysis of tissue factor pathway inhibitor-2
Published in Oncotarget (29-09-2015)“…Proteases contribute to cancer in many ways, including tumor vascularization and metastasis, and their pharmacological inhibition is a potential anticancer…”
Get full text
Journal Article -
16
The molecular assembly of amyloid aβ controls its neurotoxicity and binding to cellular proteins
Published in PloS one (23-09-2011)“…Accumulation of β-sheet-rich peptide (Aβ) is strongly associated with Alzheimer's disease, characterized by reduction in synapse density, structural…”
Get full text
Journal Article -
17
Low levels of ALS-linked Cu/Zn superoxide dismutase increase the production of reactive oxygen species and cause mitochondrial damage and death in motor neuron-like cells
Published in Journal of the neurological sciences (15-05-2005)“…Mutations of Cu/Zn superoxide dismutase (SOD1) are found in patients with familial amyotrophic lateral sclerosis (FALS). A cellular model of FALS was developed…”
Get full text
Journal Article -
18
The Contribution of p53 in the Dynamics of Cell Cycle Response to DNA Damage Interpreted by a Mathematical Model
Published in Cell cycle (Georgetown, Tex.) (15-04-2007)“…Despite numerous studies on the tumor suppressor p53, a complete picture of its role in cell arrest and killing in G1, S and G2M phases after drug treatment is…”
Get full text
Journal Article -
19
Induction of miR-21 by Retinoic Acid in Estrogen Receptor-positive Breast Carcinoma Cells
Published in The Journal of biological chemistry (01-02-2011)“…Retinoids are promising agents for the treatment/prevention of breast carcinoma. We examined the role of microRNAs in mediating the effects of…”
Get full text
Journal Article -
20
Interpreting cell cycle effects of drugs : the case of melphalan
Published in Cancer chemotherapy and pharmacology (01-04-2006)“…Multiple effects usually occur in the cell cycle, during and after the exposure to a drug, while treated cells flowing through the cycle encounter G1, S and…”
Get full text
Journal Article